Health news
Longevity, mental health, nutrition, performance and clinical news, from the Lancet, the BMJ, the WHO and other primary sources.
More news
- ClinicalEurope Accelerates Review of RevMed Cancer DrugEuropean regulators are set to accelerate their review of RevMed's cancer drug, according to STAT News. The same roundup notes concerns over Kailera's GLP-1 pill data and an FDA clearance for a Vera autoimmune therapy.
- ClinicalNHS Urges Adults in Their 50s to Return Bowel Screening KitsNew NHS England figures indicate that adults in their 50s are less likely to participate in bowel cancer screening, despite the programme identifying approximately 100 cancers each week. The health service is urging this age group to complete and return their testing kits.
- ClinicalEurope Accelerates RevMed Drug Review Amid Mixed Biotech NewsEuropean regulators are set to accelerate their review of a drug from RevMed. The development comes as Kailera faces concerns over its GLP-1 pill data, and the FDA clears a new autoimmune therapy from Vera.
- ClinicalNHS Presses People in Their 50s on Bowel Screening KitsNHS England is asking millions of people in their 50s to complete and return bowel cancer screening kits, after annual figures showed lower participation among this age group than among older cohorts.
- LifestyleIn-Womb Treatment Saves Identical Twins in World-First TrialIdentical twins Nancy and Margo received a pioneering treatment while in the womb as part of a world-first medical trial, according to BBC News. The procedure saved the twins from a rare pregnancy condition.
- ClinicalEurope to Accelerate Review of RevMed Drug, STAT ReportsEuropean regulators intend to accelerate their assessment of a drug developed by RevMed, STAT News reported, a development noted within a wider roundup of biotechnology news.
- ClinicalNHS England Presses People in Their 50s on Bowel ScreeningNHS England has called on people in their 50s to complete and return bowel screening kits, citing annual figures that show lower participation among this age group and roughly 100 cancers detected each week.
- ClinicalEurope Fast-Tracks RevMed Drug Review as Biotech News ShiftsEuropean regulators are set to speed up their review of a RevMed drug, while Kailera's GLP-1 pill data prompt concern and the FDA clears an autoimmune therapy from Vera, according to STAT News.
- ClinicalNHS Data Reveals Lower Bowel Screening Uptake in 50s Age GroupNew figures from NHS England indicate that people in their 50s are less likely to participate in bowel cancer screening, with just over half of 54-year-olds returning their kits. The health service is urging this age group to complete and return the tests.
- ClinicalEurope Accelerates RevMed Drug Review; Kailera Data FlaggedEuropean regulators plan to accelerate their assessment of a RevMed drug. Separately, Kailera’s GLP-1 pill data have prompted concerns, and the FDA cleared a Vera autoimmune therapy.
- LifestyleIn-Womb Trial Saves Identical Twins From Rare Pregnancy ConditionIdentical twins Nancy and Margo were saved from a rare pregnancy condition after receiving a pioneering treatment while still in the womb. The intervention was part of what is described as a world-first medical trial.
- ClinicalEurope to Fast-Track Review of Revolution Medicines DrugEuropean authorities are set to expedite the regulatory evaluation of a drug candidate from Revolution Medicines, signaling a potential quickened path to market for the oncology treatment.
